We are still three weeks away from the Q1 earnings season ramping up, but the reporting cycle has gotten underway already with earnings reports from 12 S&P 500 members already out. All of these initial Q1 earnings reports are from companies that have their fiscal quarters ending in February, which form part of our Q1 earnings tally.
The chart below shows the weekly reporting calendar for the S&P 500 index, with this week bringing in results from 5 index members.
This Week’s Key Reports
Red Hat – Red Hat reports after the market’s close on Monday, March 27th, with the company expected to earn 39 cents per share on $618.5 million in revenues, up +14.4% and +13.8% from the year-earlier level, respectively. The stock was down big after the last earnings report on December 21st, but has impressive gains this year – up +19.5% in the year-to-date period, outperforming the Zacks Tech sector’s +8.9% gain (the S&P 500 index is up +4.7% in that same time period).
Darden Restaurants (DRI - Free Report) – Darden reports results before the market’s open on Tuesday, March 28th, with company expected to earn $1.27 per share on $1.86 billion in revenues, up +5.8% and +1% from the year-earlier period, respectively. The company’s improved comp and margin outlook has helped the stock outperform the broader market as well as the peer restaurant industry, with the stock up +5.6% in the year-to-date period vs. a decline of -1.2% for the Zacks Restaurants industry. The last two earnings reports were not big movers of the stock, but this report could be material given the stock’s strong recent gains.
Dave & Buster’s (PLAY - Free Report) is another restaurant operator reporting results on Tuesday, March 28th. This is a relatively young player, having gone public only in the fall of 2014, with the stock up an impressive +251% since the October 2014 IPO on the back of the company’s strong growth profile. Dave & Buster’s shares are up +7.8% in the year-to-date period vs. -1.2% decline for the Zacks Restaurants industry. The last few earnings reports were big stock price movers, with the stock up big following the December quarter report when it beat on the top- and bottom lines.
Paychex (PAYX - Free Report) – Payroll processor Paychex reports results before the market’s open on Wednesday, March 29th. The company is expected to earn $0.54 per share on $798.4 million in revenues, up +7.6% on +6.1% higher revenues from the year-earlier period, respectively.
Expectations for Q1
Total Q1 earnings are expected to be up +6.4% from the same period last year on +6.4% higher revenues. This would follow +7.3% earnings growth in 2016 Q4 on +4.7%, the highest growth pace in all most two years.
Estimates for Q1 have come down as the quarter has unfolded, with the current +6.4% growth down from +10.4% at the end of December. The chart below shows how Q1 earnings growth expectations have evolved over the last three months.
Please note that while Q1 estimates have followed well traversed path that we have been seeing consistently over the last few years, the magnitude of negative revisions compares favorably to other periods, particularly in the first half of last year and all of 2015. In other words, Q1 estimates have come down, but they haven’t come down by as much.
The table below shows the summary picture for Q1, contrasted with what was actually achieved in Q4.
Please note that the Q1 earnings season would follow the strong showing on the earnings front in the preceding reporting cycle. Not only did 2016 Q4 growth reach the highest in two years, but total earnings for the quarter also reached a new quarterly record. The strong Q4 performance came after the first positive earnings growth in 2016 Q3, having declined in each of the preceding 5 quarters, as the chart below of year-over-year earnings growth for the S&P 500 index shows.
Expectations Beyond Q1
The chart below shows the Q1 earnings growth contrasted with what is expected in the following three quarters and actual results in the preceding 5 quarters. As you can see in the chart below, the growth pace is expected to ramp up in 2017.
The market is reflecting this improved earnings backdrop as the chart below of the S&P 500 relative to forward 12-month Zacks Consensus estimates shows.
Please note that the earnings backdrop has not changed in any meaningful way since the November elections, notwithstanding the market’s strong gains since then. The only exception to this comment is the Finance sector whose earnings outlook has improved as a result of the uptrend in interest rates since November 8th. It is reasonable to expect that earnings estimates will move favorably once the new administration’s growth-friendly policies get enacted. For now, however, estimates are following the long-established trend of coming down.
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here >>>
Our Best Private Investment Ideas
If you’d like to see specific recommendations to capitalize on current market conditions, there is a way you can follow all Zacks' private buys and sells in real time. Our experts cover everything from earnings surprises and insider buys to stocks under $10 and ETFs. Starting today, for the next month, you can have unrestricted access to all of our exclusive portfolios. Click here for Zacks' private trades >>
Here is a list of the 84 companies including 5 S&P 500 members reporting this week.
Company | Ticker | Current Qtr | Year-Ago Qtr | Last EPS Surprise % | Report Day | Time |
ZYNERBA PHARMA | ZYNE | -0.73 | -0.62 | 0.00% | Monday | BTO |
G-III APPAREL | GIII | -0.09 | 0.17 | -1.96% | Monday | BTO |
GLOBAL MED REIT | GMRE | 0.01 | N/A | -175.00% | Monday | BTO |
ONCONOVA THERAP | ONTX | N/A | 1.8 | -42.11% | Monday | BTO |
GAZIT GLOBE LTD | GZT | N/A | 0.29 | N/A | Monday | BTO |
VASCULAR BIOGNC | VBLT | -0.16 | -0.14 | 20.00% | Monday | BTO |
CAL-MAINE FOODS | CALM | 0.16 | 1.33 | 0.00% | Monday | BTO |
RED HAT INC | RHT | 0.39 | 0.34 | 13.51% | Monday | AMC |
WESTPORT FUEL | WPRT | -0.15 | -0.35 | 39.13% | Monday | AMC |
GRUPO AVAL SA | AVAL | 0.21 | 0.2 | 26.67% | Monday | AMC |
FOUNDATION BLDG | FBM | -0.1 | N/A | N/A | Monday | AMC |
SYNNEX CORP | SNX | 1.66 | 1.37 | 22.97% | Monday | AMC |
AUXILIO INC | AUXO | 0.08 | 0.18 | N/A | Monday | AMC |
DIGITAL ALLY IN | DGLY | N/A | -0.51 | -286.67% | Monday | AMC |
SELECTA BIOSCI | SELB | 0.32 | N/A | 10.42% | Monday | AMC |
COPEL-ADR PR B | ELP | N/A | 0.38 | N/A | Monday | N/A |
DARDEN RESTRNT | DRI | 1.27 | 1.21 | 1.59% | Tuesday | BTO |
CARNIVAL CORP | CCL | 0.35 | 0.39 | 15.52% | Tuesday | BTO |
MCCORMICK & CO | MKC | 0.75 | 0.74 | 0.00% | Tuesday | BTO |
FACTSET RESH | FDS | 1.8 | 1.59 | 2.94% | Tuesday | BTO |
RENESOLA LT-ADR | SOL | -0.8 | 0.35 | -25.00% | Tuesday | BTO |
AT HOME GRP INC | HOME | 0.27 | N/A | 50.00% | Tuesday | BTO |
IHS MARKIT LTD | INFO | 0.37 | 0.26 | 5.56% | Tuesday | BTO |
GALECTIN THERAP | GALT | N/A | -0.19 | 13.64% | Tuesday | BTO |
EVOTEC AG-ADR | EVTCY | N/A | 0.09 | 850.00% | Tuesday | BTO |
OREXIGEN THERAP | OREX | -0.54 | -1.2 | 52.58% | Tuesday | BTO |
SUPERCOND TECH | SCON | -0.55 | -1.2 | 0.00% | Tuesday | BTO |
ASTERIAS BIOTHR | AST | -0.17 | -0.21 | 11.76% | Tuesday | AMC |
CYCLACEL PHARMA | CYCC | -0.73 | -1.2 | 8.51% | Tuesday | AMC |
SONIC CORP | SONC | 0.15 | 0.18 | 9.09% | Tuesday | AMC |
OLLIES BGN OUTL | OLLI | 0.35 | 0.31 | 21.43% | Tuesday | AMC |
DAVE&BUSTRS ENT | PLAY | 0.58 | 0.53 | 92.31% | Tuesday | AMC |
LAUREATE EDUCAT | LAUR | 0.29 | N/A | N/A | Tuesday | AMC |
WESTMORELAND CO | WLB | 0.71 | -1.06 | -239.39% | Tuesday | AMC |
INTELGENX TECH | IGXT | N/A | 0 | 100.00% | Tuesday | AMC |
VERINT SYSTEMS | VRNT | 0.63 | 0.72 | 5.41% | Tuesday | AMC |
ROMACO RESOURCS | METC | N/A | N/A | N/A | Tuesday | AMC |
WOLSELEY -ADR | WOSYY | N/A | N/A | N/A | Tuesday | N/A |
PAYCHEX INC | PAYX | 0.54 | 0.5 | 1.82% | Wednesday | BTO |
UNIFIRST CORP | UNF | 1 | 1.16 | -12.66% | Wednesday | BTO |
INTL SEAWAYS | INSW | 0.31 | N/A | N/A | Wednesday | BTO |
SECUREWORKS CP | SCWX | -0.06 | -0.13 | 55.56% | Wednesday | BTO |
OMNOVA SOLUTION | OMN | 0.05 | 0.04 | 0.00% | Wednesday | BTO |
SUNWORKS INC | SUNW | -0.14 | 0.06 | -341.67% | Wednesday | BTO |
LULULEMON ATHLT | LULU | 1.01 | 0.85 | 9.30% | Wednesday | AMC |
WILDHORSE RESRC | WRD | 0.07 | N/A | N/A | Wednesday | AMC |
MARRONE BIO INV | MBII | -0.29 | -0.45 | -31.82% | Wednesday | AMC |
SIGMA DESIGNS | SIGM | -0.21 | -0.02 | 400.00% | Wednesday | AMC |
EXFO INC | EXFO | 0.04 | 0.06 | 40.00% | Wednesday | AMC |
GEVO INC | GEVO | -0.96 | -8.8 | 0.00% | Wednesday | AMC |
PROGRESS SOFTWA | PRGS | 0.2 | 0.18 | 14.58% | Wednesday | AMC |
FULLER(HB) CO | FUL | 0.49 | 0.43 | -1.33% | Wednesday | AMC |
FORTERRA INC | FRTA | 0.01 | N/A | N/A | Wednesday | AMC |
WORTHINGTON IND | WOR | 0.67 | 0.46 | -6.25% | Wednesday | AMC |
SCIENCE APP INT | SAIC | 0.8 | 0.74 | 8.33% | Thursday | BTO |
TITAN MACHINERY | TITN | -0.19 | -1.31 | -116.67% | Thursday | BTO |
NEURODERM LTD | NDRM | -0.47 | -0.31 | 0.00% | Thursday | BTO |
ALDEYRA THERAPT | ALDX | -0.51 | -0.47 | 7.32% | Thursday | BTO |
AFFIMED THERAP | AFMD | -0.3 | -0.21 | -40.00% | Thursday | BTO |
CLEAN DIESEL | CDTI | -0.14 | 0.05 | -34.78% | Thursday | BTO |
LINDSAY CORP | LNN | 0.38 | 0.42 | -87.30% | Thursday | BTO |
ANGIODYNAMICS | ANGO | 0.15 | 0.15 | 18.75% | Thursday | BTO |
CHINA AUTO SYS | CAAS | N/A | 0.22 | 50.00% | Thursday | BTO |
HENNES&MAURIT | HNNMY | N/A | 0.04 | 14.29% | Thursday | BTO |
INVENTURE FOODS | SNAK | -0.07 | -0.08 | -533.33% | Thursday | BTO |
LIQTECH INTL | LIQT | -0.01 | 0 | -300.00% | Thursday | BTO |
EAGLE BULK SHPG | EGLE | -0.26 | -42.4 | N/A | Thursday | AMC |
MARATHON PATENT | MARA | -0.36 | -0.07 | -68.00% | Thursday | AMC |
DICERNA PHARMA | DRNA | -0.73 | -0.76 | 21.84% | Thursday | AMC |
FRANKLIN COVEY | FC | -0.22 | -0.03 | -163.64% | Thursday | AMC |
UNI-PIXEL INC | UNXL | -0.14 | -0.47 | -41.67% | Thursday | AMC |
AEHR TEST SYS | AEHR | -0.08 | -0.23 | -28.57% | Thursday | AMC |
NETLIST INC | NLST | -0.07 | -0.09 | 11.11% | Thursday | AMC |
RXI PHARMACEUT | RXII | N/A | -0.4 | 0.00% | Thursday | AMC |
SOCIAL REALITY | SRAX | -0.24 | -0.05 | -66.67% | Thursday | AMC |
ONE GROUP HOSP | STKS | N/A | 0.18 | 700.00% | Thursday | AMC |
UQM TECH INC | UQM | N/A | -0.03 | -66.67% | Thursday | AMC |
WIDEPOINT CORP | WYY | N/A | -0.01 | 100.00% | Thursday | AMC |
VOXELJET AG-ADR | VJET | N/A | -0.14 | -133.33% | Thursday | AMC |
PARKERVISION | PRKR | N/A | -3.3 | N/A | Thursday | AMC |
BLACKBERRY LTD | BBRY | -0.04 | -0.06 | 75.00% | Friday | BTO |
SORL AUTO PARTS | SORL | N/A | 0.31 | 6.25% | Friday | BTO |
MEDICAL TRANSCR | MTBC | N/A | -0.01 | 90.91% | Friday | BTO |
FLEXIBLE SOLTNS | FSI | N/A | 0.03 | -50.00% | Friday | AMC |
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
We are still three weeks away from the Q1 earnings season ramping up, but the reporting cycle has gotten underway already with earnings reports from 12 S&P 500 members already out. All of these initial Q1 earnings reports are from companies that have their fiscal quarters ending in February, which form part of our Q1 earnings tally.
The chart below shows the weekly reporting calendar for the S&P 500 index, with this week bringing in results from 5 index members.
This Week’s Key Reports
Red Hat – Red Hat reports after the market’s close on Monday, March 27th, with the company expected to earn 39 cents per share on $618.5 million in revenues, up +14.4% and +13.8% from the year-earlier level, respectively. The stock was down big after the last earnings report on December 21st, but has impressive gains this year – up +19.5% in the year-to-date period, outperforming the Zacks Tech sector’s +8.9% gain (the S&P 500 index is up +4.7% in that same time period).
Darden Restaurants (DRI - Free Report) – Darden reports results before the market’s open on Tuesday, March 28th, with company expected to earn $1.27 per share on $1.86 billion in revenues, up +5.8% and +1% from the year-earlier period, respectively. The company’s improved comp and margin outlook has helped the stock outperform the broader market as well as the peer restaurant industry, with the stock up +5.6% in the year-to-date period vs. a decline of -1.2% for the Zacks Restaurants industry. The last two earnings reports were not big movers of the stock, but this report could be material given the stock’s strong recent gains.
Dave & Buster’s (PLAY - Free Report) is another restaurant operator reporting results on Tuesday, March 28th. This is a relatively young player, having gone public only in the fall of 2014, with the stock up an impressive +251% since the October 2014 IPO on the back of the company’s strong growth profile. Dave & Buster’s shares are up +7.8% in the year-to-date period vs. -1.2% decline for the Zacks Restaurants industry. The last few earnings reports were big stock price movers, with the stock up big following the December quarter report when it beat on the top- and bottom lines.
Paychex (PAYX - Free Report) – Payroll processor Paychex reports results before the market’s open on Wednesday, March 29th. The company is expected to earn $0.54 per share on $798.4 million in revenues, up +7.6% on +6.1% higher revenues from the year-earlier period, respectively.
Expectations for Q1
Total Q1 earnings are expected to be up +6.4% from the same period last year on +6.4% higher revenues. This would follow +7.3% earnings growth in 2016 Q4 on +4.7%, the highest growth pace in all most two years.
Estimates for Q1 have come down as the quarter has unfolded, with the current +6.4% growth down from +10.4% at the end of December. The chart below shows how Q1 earnings growth expectations have evolved over the last three months.
Please note that while Q1 estimates have followed well traversed path that we have been seeing consistently over the last few years, the magnitude of negative revisions compares favorably to other periods, particularly in the first half of last year and all of 2015. In other words, Q1 estimates have come down, but they haven’t come down by as much.
The table below shows the summary picture for Q1, contrasted with what was actually achieved in Q4.
Please note that the Q1 earnings season would follow the strong showing on the earnings front in the preceding reporting cycle. Not only did 2016 Q4 growth reach the highest in two years, but total earnings for the quarter also reached a new quarterly record. The strong Q4 performance came after the first positive earnings growth in 2016 Q3, having declined in each of the preceding 5 quarters, as the chart below of year-over-year earnings growth for the S&P 500 index shows.
Expectations Beyond Q1
The chart below shows the Q1 earnings growth contrasted with what is expected in the following three quarters and actual results in the preceding 5 quarters. As you can see in the chart below, the growth pace is expected to ramp up in 2017.
The market is reflecting this improved earnings backdrop as the chart below of the S&P 500 relative to forward 12-month Zacks Consensus estimates shows.
Please note that the earnings backdrop has not changed in any meaningful way since the November elections, notwithstanding the market’s strong gains since then. The only exception to this comment is the Finance sector whose earnings outlook has improved as a result of the uptrend in interest rates since November 8th. It is reasonable to expect that earnings estimates will move favorably once the new administration’s growth-friendly policies get enacted. For now, however, estimates are following the long-established trend of coming down.
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here >>>
Our Best Private Investment Ideas
If you’d like to see specific recommendations to capitalize on current market conditions, there is a way you can follow all Zacks' private buys and sells in real time. Our experts cover everything from earnings surprises and insider buys to stocks under $10 and ETFs. Starting today, for the next month, you can have unrestricted access to all of our exclusive portfolios. Click here for Zacks' private trades >>
Here is a list of the 84 companies including 5 S&P 500 members reporting this week.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on PAYX - FREE
Get the latest research report on DRI - FREE
Get the latest research report on PLAY - FREE